Difference between revisions of "TRANSMIT"
From Bioblast
Laner Verena (talk | contribs) |
Laner Verena (talk | contribs) |
||
Line 5: | Line 5: | ||
â__TOC__ | â__TOC__ | ||
== TRANSMIT Marie SkĆodowska-Curie PhD Fellowship with OROBOROS INSTRUMENTS / Medical University Innsbruck == | |||
* [[File:Open_position_TRANSMIT_ORO.pdf| Open position TRANSMIT project at OROBOROS INSTRUMENTS]] | |||
[[Image:European_commission_logo.pngâ|right|150px|European commission]] | [[Image:European_commission_logo.pngâ|right|150px|European commission]] |
Revision as of 10:12, 9 March 2017
TRANSMIT
- TRANSMIT - TRANSlating the role of MItochondria in Tumorigenesis
â
TRANSMIT Marie SkĆodowska-Curie PhD Fellowship with OROBOROS INSTRUMENTS / Medical University Innsbruck
Cancer is not only a genetic, but also a metabolic disease
- The consolidation of the knowledge that cancer is not only a genetic, but also a metabolic disease, has led scientists to investigate the intricate metabolic plasticity that transformed cells must undergo to survive the adverse tumor microenvironment conditions, and the contribution of oncogenes and tumor suppressors in shaping metabolism. In this scenario, genetic, biochemical and clinical evidence places mitochondria as key actors in cancer metabolic restructuring, not only because these organelles play a crucial role in energy production and formation of biosynthetic intermediates, but also because occurrence of mutations in both nuclear and mtDNA encoding metabolic enzymes is associated with different types of cancer.
Objectives
- TRANSMIT aims to dissect the metabolic remodeling in human cancers, placing the focus on the role of mitochondria and bridging basic research to the improvement/development of therapeutic strategies.
- TRANSMIT fosters the communication of this emerging field to the patients and their families. Accordingly, TRANSMIT will create a network of seven countries, including world-leading basic science and clinical centers of excellence, several industrial partners with up-to-date technologies, as well as non-profit foundations and associations who care for cancer patients.
- By creating the critical mass of scientific excellence, TRANSMIT will allow to transfer the current knowledge into the wide field of cancer research, translating scientific and technical advances to the education and training of eleven Early Stage Researchers. TRANSMIT will implement training-through-research dedicated to unravel the metabolic features of cancer, as well as to provide a full portfolio of complementary skills through the creation of a network of basic, translational and industrial laboratories, devoted to a multidisciplinary/multisectorial education of young scientists.
- TRANSMIT key methodologies and key objectives: The project is structured in three scientific WPs. For each WP, several ESRs are recruited as indicated below the WP title. Scientific WPs share the key methodologies indicated within the four sectors of the romboid in light grey. The implementation of key methodologies in pairs allows the achievement of the key objectives indicated by the dark grey arrowheads.
Coordinator
- Alma Mater Studiorum â UniversitĂ di Bologna - IT
- Submitted by Anna-Maria Porcelli and Serena Paterlini (University of Bologna)
List of participants
- Alma Mater Studiorum â UniversitĂ di Bologna - IT (lead partner)
- Universite Catholique de Louvain - BE
- OROBOROS INSTRUMENTS GmbH - AT
- Justus Liebig UniversitÀt Giessen - DE
- GemeinnĂŒtzige Salzburger Landeskliniken Betriebsgesellschaft - AT
- Karolinska Institutet - SE
- The Chancellor, Masters and Scholars of the University of Cambridge - UK
- Association pour le dĂ©veloppement de l'enseignement et des recherches aupres des universities et des enterprises dâaquitaine - FR
- Biocrates Life Sciences AG - AT
- AvantiCell Science Ltd - UK
Partner organisations
- Official announcement of the Marie-Curie SkĆodowska Action TRANSMIT: http://cordis.europa.eu/project/rcn/205395_en.html
- OROBOROS MitoFit Research Laboratory